AGH.ASX
Drawbacks of the TGA’s cannabis changes for listed pot stocks
Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that should be more freely available to the ailing masses. But the path to the pharmacy is likely to be harder than they […]
Althea begins online medicinal cannabis sales supported by telemedicine
Two weeks since securing a new patient referral agreement and approvals for more clinic locations, medicinal cannabis company Althea Group (ASX: AGH) has turned its attentions to making commercial progress online. In a statement this morning, Althea said it will begin online sales of medicinal cannabis from its Althea Concierge platform, including delivery in what the […]
Althea’s MyAccess Clinics boosts UK expansion, teams up with Drug Science
Pharma company Althea Group (ASX: AGH) has unveiled a string of advances in the UK citing “significant progress” in securing a new patient referral agreement, further approvals for more clinic locations and an agreement with an independent scientific committee. With respect to the UK, the company indicated it is making incremental progress and ultimately seeks to […]
Althea gets set for German market expansion after executing supply agreement with Nimbus Health
Pharmaceutical company Althea Group (ASX: AGH) has added Germany to its list of active markets following the signing of a three-year supply and distribution agreement with wholesaler Nimbus Health. Althea will now see its products sold in Australia, the UK, Canada and Germany as part of a sequential global expansion strategy. Nimbus is a German […]